Coagulopathy associated with peritoneovenous shunting

Area of Science:

• Medical Devices
• Surgical Procedures
• Hematology

Background:

• Ascites, a common complication in various diseases, often requires palliative treatment.
• The Le Veen shunt is a device used to manage refractory ascites.
• Disseminated intravascular coagulation (DIC) is a potential life-threatening complication associated with medical devices and surgical interventions.

Purpose of the Study:

• To evaluate the efficacy of Le Veen shunts in alleviating ascites.
• To investigate the incidence and outcomes of disseminated intravascular coagulation (DIC) following Le Veen shunt placement.
• To assess the impact of early intervention on coagulopathy management.

Main Methods:

• Retrospective analysis of patients who underwent Le Veen shunt placement for ascites.
• Monitoring for clinical and laboratory signs of disseminated intravascular coagulation (DIC).
• Evaluation of treatment strategies for coagulopathy, including shunt ligation.

Main Results:

• Le Veen shunts successfully treated ascites in 79% of patients.
• Clinical DIC occurred in 37% of patients, with a mortality rate of 78% among those affected.
• Laboratory evidence of DIC was noted in an additional 21% without significant bleeding.
• Early shunt ligation and supportive care reversed coagulopathy in 50% of affected patients.

Conclusions:

• Le Veen shunts are effective for ascites management but carry a significant risk of DIC.
• Prompt recognition and management of DIC, including shunt removal, are crucial for improving patient outcomes.
• Further research into prophylactic measures and optimized management protocols for DIC in patients with Le Veen shunts is warranted.